141 related articles for article (PubMed ID: 23926182)
1. The direct renin inhibitor aliskiren localizes and persists in rat kidneys.
Feldman DL; Jin L; Xuan H; Persohn E; Zhou W; Schuetz H; Park JK; Muller DN; Luft FC
Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1593-602. PubMed ID: 23926182
[TBL] [Abstract][Full Text] [Related]
2. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
Savoia C; Arrabito E; Parente R; Sada L; Madaro L; Nicoletti C; Zezza L; Alonzo A; Rubattu S; Michelini S; Muller DN; Volpe M
Clin Sci (Lond); 2013 Aug; 125(4):183-9. PubMed ID: 23438195
[TBL] [Abstract][Full Text] [Related]
3. Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats.
Pilz B; Shagdarsuren E; Wellner M; Fiebeler A; Dechend R; Gratze P; Meiners S; Feldman DL; Webb RL; Garrelds IM; Jan Danser AH; Luft FC; Müller DN
Hypertension; 2005 Sep; 46(3):569-76. PubMed ID: 16103264
[TBL] [Abstract][Full Text] [Related]
4. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
Rakusan D; Kujal P; Kramer HJ; Husková Z; Vanourková Z; Vernerová Z; Mrázová I; Thumová M; Cervenka L; Vanecková I
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F758-66. PubMed ID: 20668096
[TBL] [Abstract][Full Text] [Related]
5. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.
Feldman DL; Jin L; Xuan H; Contrepas A; Zhou Y; Webb RL; Mueller DN; Feldt S; Cumin F; Maniara W; Persohn E; Schuetz H; Jan Danser AH; Nguyen G
Hypertension; 2008 Jul; 52(1):130-6. PubMed ID: 18490518
[TBL] [Abstract][Full Text] [Related]
6. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
[TBL] [Abstract][Full Text] [Related]
7. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
[TBL] [Abstract][Full Text] [Related]
8. Despite similar reduction of blood pressure and renal ANG II and ET-1 levels aliskiren but not losartan normalizes albuminuria in hypertensive Ren-2 rats.
Vaňourková Z; Kramer HJ; Husková Z; Cervenka L; Vaněčková I
Physiol Res; 2010; 59(3):339-345. PubMed ID: 20666571
[TBL] [Abstract][Full Text] [Related]
9. Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
Hypertension; 2011 Apr; 57(4):852-8. PubMed ID: 21321303
[TBL] [Abstract][Full Text] [Related]
10. Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury--beyond the direct renin inhibition.
Sun CY; Cherng WJ; Jian HZ; Hsu HH; Wu IW; Hsu HJ; Wu MS
Hypertens Res; 2012 Mar; 35(3):304-11. PubMed ID: 22089535
[TBL] [Abstract][Full Text] [Related]
11. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
Campbell DJ; Zhang Y; Kelly DJ; Gilbert RE; McCarthy DJ; Shi W; Smyth GK
Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.
Andersen K; Weinberger MH; Constance CM; Ali MA; Jin J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):157-67. PubMed ID: 19617271
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective effect of aliskiren on renal ischemia/reperfusion injury in rats: electron microscopy and molecular study.
Ziypak T; Halici Z; Alkan E; Akpinar E; Polat B; Adanur S; Cadirci E; Ferah I; Bayir Y; Karakus E; Mercantepe T
Ren Fail; 2015 Mar; 37(2):343-54. PubMed ID: 25524622
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren reduces portal pressure in portal hypertensive rats.
Chang CC; Lee WS; Huang HC; Lee FY; Wang SS; Lin HC; Nong JY; Lee SD
Eur J Clin Invest; 2012 May; 42(5):526-33. PubMed ID: 22023532
[TBL] [Abstract][Full Text] [Related]
15. Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension.
Fischer R; Dechend R; Qadri F; Markovic M; Feldt S; Herse F; Park JK; Gapelyuk A; Schwarz I; Zacharzowsky UB; Plehm R; Safak E; Heuser A; Schirdewan A; Luft FC; Schunck WH; Muller DN
Hypertension; 2008 Feb; 51(2):540-6. PubMed ID: 18158339
[TBL] [Abstract][Full Text] [Related]
16. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
17. Aliskiren and valsartan in combination is a promising therapy for hypertensive renal injury in rats.
Abdel Kawy HS
Clin Exp Hypertens; 2018; 40(6):560-568. PubMed ID: 29172824
[TBL] [Abstract][Full Text] [Related]
18. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
19. Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats.
Hermanowicz JM; Hermanowicz A; Buczko P; Leszczynska A; Tankiewicz-Kwedlo A; Mogielnicki A; Buczko W
Thromb Res; 2013 Jan; 131(1):e39-44. PubMed ID: 23174623
[TBL] [Abstract][Full Text] [Related]
20. Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure.
Westermann D; Riad A; Lettau O; Roks A; Savvatis K; Becher PM; Escher F; Jan Danser AH; Schultheiss HP; Tschöpe C
Hypertension; 2008 Dec; 52(6):1068-75. PubMed ID: 18955663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]